AU Stock MarketDetailed Quotes

VFY Vitrafy Life Sciences Ltd

Watchlist
  • 1.290
  • -0.010-0.77%
20min DelayNot Open Mar 20 13:31 AET
82.37MMarket Cap-7.91P/E (Static)

Vitrafy Life Sciences Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Vitrafy Life Sciences Ltd H1 FY2025 Earnings Date

Currency：AUDFeb 6, 2025

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
--
7.70K
--
--
EPS
--
-0.99
--
--
Analyst Rating
Strong Buy

Mar 15, 2025

Vitrafy Life Sciences Ltd Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency:

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2026/FY-- / 5.143M--
--2025/FY-- / 1.071M--
DatePeriodRevenue/EstimateEarnings Call
--2026/FY-- / 5.143M--
--2025/FY-- / 1.071M--
--------
--------
--------

Unlock Free Earnings Estimates

Vitrafy Life Sciences Ltd Earnings Reports

  • Vitrafy Life Sciences Ltd: FY25 Half Year Results Presentation

    Feb 5 16:26 ET

  • Vitrafy Life Sciences Ltd: FY25 Appendix 4D and Half Year Report

    Feb 5 16:26 ET

  • Vitrafy Life Sciences Ltd: Vitrafy Half Year FY25 Investor Briefing

    Feb 3 17:19 ET

  • Vitrafy Life Sciences Ltd: Annual Report - 30 June 2024

    Nov 22, 2024 00:58 ET

    • Read more

    Market Insights
    ASX High Dividend ASX High Dividend
    Symbol Div YieldTTM Dividend TTM
    CommBank
    CBA
    3.19% 4.65
    Westpac Banking Corp
    WBC
    4.80% 1.47
    ANZ Group Holdings Ltd
    ANZ
    6.07% 1.77
    National Australia Bank Ltd
    NAB
    5.08% 1.68
    Telstra Group Ltd
    TLS
    4.23% 0.18

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Mar 15, 2025

    Strong Buy

    • Strong Buy

      100.00%

    • Buy

      0.00%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data